世界の肺がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lung Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4443
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、肺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・肺がん分子診断の市場動向
・企業の競争状況、市場シェア
・肺がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ）
・肺がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究）
・肺がん分子診断の北米市場規模2016-2027（アメリカ、カナダ）
・肺がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・肺がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・肺がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・肺がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Foundationmedicine、Roche、Qiagen、Liferiver、Tellgen、Genetech、Gpmedical、Sansure、Amoydx、Mole、Annoroad）
・結論

A molecular approach for diagnosing lung cancer

Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market
The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Molecular Diagnostics market.

Global Lung Cancer Molecular Diagnostics Scope and Market Size
Lung Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Foundationmedicine
Roche
Qiagen
Liferiver
Tellgen
Genetech
Gpmedical
Sansure
Amoydx
Mole
Annoroad

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Lung Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Lung Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Lung Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Lung Cancer Molecular Diagnostics Market Trends
2.3.2 Lung Cancer Molecular Diagnostics Market Drivers
2.3.3 Lung Cancer Molecular Diagnostics Market Challenges
2.3.4 Lung Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Lung Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Molecular Diagnostics Revenue
3.4 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Molecular Diagnostics Revenue in 2020
3.5 Lung Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Lung Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Lung Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Lung Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Lung Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Lung Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lung Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Foundationmedicine
11.1.1 Foundationmedicine Company Details
11.1.2 Foundationmedicine Business Overview
11.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Introduction
11.1.4 Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Foundationmedicine Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Lung Cancer Molecular Diagnostics Introduction
11.2.4 Roche Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Lung Cancer Molecular Diagnostics Introduction
11.3.4 Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 Liferiver
11.4.1 Liferiver Company Details
11.4.2 Liferiver Business Overview
11.4.3 Liferiver Lung Cancer Molecular Diagnostics Introduction
11.4.4 Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Liferiver Recent Development
11.5 Tellgen
11.5.1 Tellgen Company Details
11.5.2 Tellgen Business Overview
11.5.3 Tellgen Lung Cancer Molecular Diagnostics Introduction
11.5.4 Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Tellgen Recent Development
11.6 Genetech
11.6.1 Genetech Company Details
11.6.2 Genetech Business Overview
11.6.3 Genetech Lung Cancer Molecular Diagnostics Introduction
11.6.4 Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Genetech Recent Development
11.7 Gpmedical
11.7.1 Gpmedical Company Details
11.7.2 Gpmedical Business Overview
11.7.3 Gpmedical Lung Cancer Molecular Diagnostics Introduction
11.7.4 Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Gpmedical Recent Development
11.8 Sansure
11.8.1 Sansure Company Details
11.8.2 Sansure Business Overview
11.8.3 Sansure Lung Cancer Molecular Diagnostics Introduction
11.8.4 Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Sansure Recent Development
11.9 Amoydx
11.9.1 Amoydx Company Details
11.9.2 Amoydx Business Overview
11.9.3 Amoydx Lung Cancer Molecular Diagnostics Introduction
11.9.4 Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Amoydx Recent Development
11.10 Mole
11.10.1 Mole Company Details
11.10.2 Mole Business Overview
11.10.3 Mole Lung Cancer Molecular Diagnostics Introduction
11.10.4 Mole Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Mole Recent Development
11.11 Annoroad
11.11.1 Annoroad Company Details
11.11.2 Annoroad Business Overview
11.11.3 Annoroad Lung Cancer Molecular Diagnostics Introduction
11.11.4 Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Annoroad Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Lung Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lung Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lung Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lung Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lung Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Lung Cancer Molecular Diagnostics Market Trends
Table 13. Lung Cancer Molecular Diagnostics Market Drivers
Table 14. Lung Cancer Molecular Diagnostics Market Challenges
Table 15. Lung Cancer Molecular Diagnostics Market Restraints
Table 16. Global Lung Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lung Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Lung Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Lung Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lung Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lung Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Lung Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lung Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Foundationmedicine Company Details
Table 64. Foundationmedicine Business Overview
Table 65. Foundationmedicine Lung Cancer Molecular Diagnostics Product
Table 66. Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Foundationmedicine Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Lung Cancer Molecular Diagnostics Product
Table 71. Roche Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Qiagen Company Details
Table 74. Qiagen Business Overview
Table 75. Qiagen Lung Cancer Molecular Diagnostics Product
Table 76. Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Qiagen Recent Development
Table 78. Liferiver Company Details
Table 79. Liferiver Business Overview
Table 80. Liferiver Lung Cancer Molecular Diagnostics Product
Table 81. Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Liferiver Recent Development
Table 83. Tellgen Company Details
Table 84. Tellgen Business Overview
Table 85. Tellgen Lung Cancer Molecular Diagnostics Product
Table 86. Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Tellgen Recent Development
Table 88. Genetech Company Details
Table 89. Genetech Business Overview
Table 90. Genetech Lung Cancer Molecular Diagnostics Product
Table 91. Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Genetech Recent Development
Table 93. Gpmedical Company Details
Table 94. Gpmedical Business Overview
Table 95. Gpmedical Lung Cancer Molecular Diagnostics Product
Table 96. Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Gpmedical Recent Development
Table 98. Sansure Company Details
Table 99. Sansure Business Overview
Table 100. Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Sansure Recent Development
Table 102. Amoydx Company Details
Table 103. Amoydx Business Overview
Table 104. Amoydx Lung Cancer Molecular Diagnostics Product
Table 105. Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Amoydx Recent Development
Table 107. Mole Company Details
Table 108. Mole Business Overview
Table 109. Mole Lung Cancer Molecular Diagnostics Product
Table 110. Mole Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Mole Recent Development
Table 112. Annoroad Company Details
Table 113. Annoroad Business Overview
Table 114. Annoroad Lung Cancer Molecular Diagnostics Product
Table 115. Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Annoroad Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Lung Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Lung Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Lung Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lung Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lung Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Lung Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Lung Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Lung Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lung Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Foundationmedicine Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Qiagen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Liferiver Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Tellgen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Genetech Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Gpmedical Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Sansure Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Amoydx Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Mole Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Annoroad Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年）

Global Laryngeal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4412 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、喉頭がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4649 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、膵臓がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年）

Global Bladder Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3914 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、膀胱がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模...

世界の肝がん分子診断市場規模・現状・予測（2021年-2027年）

Global Liver Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4434 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肝がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Thyroid Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4953 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、甲状腺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米...

世界の卵巣がん分子診断市場規模・現状・予測（2021年-2027年）

Global Ovarian Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4637 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、卵巣がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の胃がん分子診断市場規模・現状・予測（2021年-2027年）

Global Stomach Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4909 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、胃がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Gallbladder Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4516 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、胆嚢がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing thyroid cancer Market Analysis and Insights: Global Thyroid Cancer Molecular Diagnostics Market The global Thyroid Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の胃がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing stomach cancer Market Analysis and Insights: Global Stomach Cancer Molecular Diagnostics Market The global Stomach Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…